Mufg Securities Americas Inc. raised its holdings in CME Group Inc. (NASDAQ:CME – Free Report) by 25.2% during the second quarter, HoldingsChannel.com reports. The firm owned 7,986 shares of the financial services provider’s stock after buying an additional 1,607 shares during the period. Mufg Securities Americas Inc.’s holdings in CME Group were worth $2,201,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Private Advisor Group LLC increased its position in shares of CME Group by 3.6% in the 1st quarter. Private Advisor Group LLC now owns 7,251 shares of the financial services provider’s stock worth $1,924,000 after purchasing an additional 251 shares during the last quarter. AE Wealth Management LLC increased its holdings in CME Group by 18.4% in the first quarter. AE Wealth Management LLC now owns 1,095 shares of the financial services provider’s stock valued at $291,000 after buying an additional 170 shares during the last quarter. SFE Investment Counsel acquired a new stake in CME Group during the first quarter valued at approximately $281,000. Advisor OS LLC bought a new position in CME Group during the 1st quarter worth approximately $204,000. Finally, Lifeworks Advisors LLC lifted its holdings in CME Group by 27.0% during the 1st quarter. Lifeworks Advisors LLC now owns 1,706 shares of the financial services provider’s stock worth $453,000 after buying an additional 363 shares during the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.
CME Group Stock Down 0.8%
CME Group stock opened at $273.09 on Friday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a one year low of $224.62 and a one year high of $290.79. The company has a 50-day simple moving average of $268.74 and a 200-day simple moving average of $272.78. The firm has a market capitalization of $98.48 billion, a P/E ratio of 26.46, a P/E/G ratio of 4.41 and a beta of 0.38.
CME Group Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.8%. The ex-dividend date is Friday, December 12th. CME Group’s dividend payout ratio (DPR) is currently 48.45%.
Analyst Upgrades and Downgrades
CME has been the subject of a number of research analyst reports. Piper Sandler upped their price target on CME Group from $296.00 to $313.00 and gave the company an “overweight” rating in a research report on Thursday, November 13th. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and increased their target price for the stock from $275.00 to $300.00 in a report on Thursday, September 25th. JPMorgan Chase & Co. raised their price target on shares of CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research report on Tuesday, October 14th. Raymond James Financial lowered their price objective on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research report on Monday, October 13th. Finally, Jefferies Financial Group cut their target price on shares of CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a report on Friday, October 10th. Eight analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Hold” and an average target price of $287.65.
Check Out Our Latest Stock Report on CME
Insider Activity
In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. The trade was a 4.76% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Timothy Francis Mccourt sold 379 shares of the firm’s stock in a transaction on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the transaction, the insider directly owned 9,508 shares in the company, valued at $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 14,043 shares of company stock worth $3,791,486 over the last ninety days. 0.30% of the stock is currently owned by company insiders.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Read More
- Five stocks we like better than CME Group
- Consumer Staples Stocks, Explained
- MarketBeat Week in Review – 11/17 – 11/21
- Airline Stocks – Top Airline Stocks to Buy Now
- A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves
- What is the Nikkei 225 index?
- 12 Analysts Just Raised CrowdStrike Targets—Here’s What They See Coming
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
